| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 1048 |
| 1 | ASPIRIN | 323 |
| 2 | ASPIRIN 325 MG | 310 |
| 3 | ASPIRIN 81 MG | 310 |
| 4 | METFORMIN | 309 |
| 5 | ADALIMUMAB | 243 |
| 6 | METFORMIN ER 500 MG | 235 |
| 7 | METFORMIN ER 750 MG | 235 |
| 8 | ERGOCALCIFEROL | 225 |
| 9 | INTERFERON BETA-1A | 218 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AFLIBERCEPT | 1048 | 0.0334 |
| 1 | BROLUCIZUMAB | 106 | 0.0291 |
| 2 | ERGOCALCIFEROL | 225 | 0.0076 |
| 3 | RANIBIZUMAB | 135 | 0.0051 |
| 4 | CARBOXYMETHYLCELLULOSE SODIUM | 20 | 0.0035 |
| 5 | LIFITEGRAST | 41 | 0.0025 |
| 6 | FARICIMAB | 21 | 0.0024 |
| 7 | TOPIRAMATE | 114 | 0.0022 |
| 8 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 27 | 0.0022 |
| 9 | TIMOLOL MALEATE | 22 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1212 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 627 |
| 2 | Corticosteroid [EPC] | 440 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 340 |
| 4 | Benzodiazepine [EPC] | 282 |
| 5 | Insulin Analog [EPC] | 274 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 263 |
| 7 | Interferon beta [EPC] | 237 |
| 8 | Proton Pump Inhibitor [EPC] | 225 |
| 9 | Provitamin D2 Compound [EPC] | 225 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 225 | 0.0076 |
| 1 | Benzodiazepine Antagonist [EPC] | 6 | 0.0068 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1212 | 0.0065 |
| 3 | Semifluorinated Alkane [EPC] | 14 | 0.0060 |
| 4 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 5 | Antiseptic [EPC] | 16 | 0.0037 |
| 6 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 41 | 0.0025 |
| 9 | Integrin Receptor Antagonist [EPC] | 181 | 0.0021 |